Indiana Administrative Code
Title 410 - INDIANA DEPARTMENT OF HEALTH
Article 1 - COMMUNICABLE DISEASE CONTROL
Rule 2.5 - Disease Reporting and Control
- Section 2.5-1 - Applicability
- Section 2.5-2 - "Active surveillance" defined
- Section 2.5-3 - "Airborne precautions" defined
- Section 2.5-4 - "Approval" defined
- Section 2.5-5 - "Bloodborne pathogens" defined
- Section 2.5-6 - "Blood center" defined
- Section 2.5-7 - "Carrier" defined
- Section 2.5-8 - "Case" defined
- Section 2.5-9 - "Case ascertainment" defined
- Section 2.5-10 - "Case management" defined
- Section 2.5-11 - "Child" defined
- Section 2.5-12 - "Cleaning" defined
- Section 2.5-13 - "Commissioner" defined
- Section 2.5-14 - "Communicable disease" defined
- Section 2.5-15 - "Concurrent disinfection" defined
- Section 2.5-16 - "Confirmed foodborne disease outbreak" defined
- Section 2.5-17 - "Contact" defined
- Section 2.5-18 - "Contact precautions" defined
- Section 2.5-19 - "Contamination" defined
- Section 2.5-20 - "Control measures" defined
- Section 2.5-21 - "Counseling and testing site" defined
- Section 2.5-22 - "Daycare facility" defined
- Section 2.5-23 - "Daycare worker" defined
- Section 2.5-24 - "Department" defined
- Section 2.5-25 - "Directly observed therapy" or "DOT" defined
- Section 2.5-26 - "Disease intervention specialist" or "DIS" defined
- Section 2.5-27 - "Disinfect" defined
- Section 2.5-28 - "Droplet precautions" defined
- Section 2.5-29 - "Expedited partner therapy" or "EPT" defined
- Section 2.5-30 - "Food employee" defined
- Section 2.5-31 - "Food establishment" defined
- Section 2.5-32 - "Hand washing procedures" defined
- Section 2.5-33 - "HAV" defined
- Section 2.5-34 - "HBV" defined
- Section 2.5-35 - "HCV" defined
- Section 2.5-36 - "Health care facility" defined
- Section 2.5-37 - "Health care worker" defined
- Section 2.5-38 - "Health practitioner" defined
- Section 2.5-39 - "HEV" defined
- Section 2.5-40 - "Highly susceptible population" defined
- Section 2.5-41 - "HIV" defined
- Section 2.5-42 - "HIV infection/disease" defined
- Section 2.5-43 - "Infant" defined
- Section 2.5-44 - "Influenza-associated death" defined
- Section 2.5-45 - "Interferon gamma release assay" or "IGRA" defined
- Section 2.5-46 - "Invasive disease" defined
- Section 2.5-47 - "Isolation" defined
- Section 2.5-48 - "Latent tuberculosis infection" or "LTBI" defined
- Section 2.5-49 - "Local health officer" defined
- Section 2.5-50 - "Mantoux tuberculin skin test" or "TST" defined
- Section 2.5-51 - "Medical laboratory" defined
- Section 2.5-52 - "Multiple drug-resistant tuberculosis" or "MDR tuberculosis" defined
- Section 2.5-53 - "Other potentially infectious materials" defined
- Section 2.5-54 - "Outbreak" defined
- Section 2.5-55 - "Partner services" defined
- Section 2.5-56 - "Person in charge" defined
- Section 2.5-57 - "Postsecondary facility" defined
- Section 2.5-58 - "Preschool" defined
- Section 2.5-59 - "Prophylaxis" defined
- Section 2.5-60 - "Quarantine" defined
- Section 2.5-61 - "Ready-to-eat food" defined
- Section 2.5-62 - "Regulatory authority" defined
- Section 2.5-63 - "Residential institution" defined
- Section 2.5-64 - "Restrict" defined
- Section 2.5-65 - "Restriction of activities" defined
- Section 2.5-66 - "Sexually transmitted disease" defined
- Section 2.5-67 - "Standard precautions" defined
- Section 2.5-68 - "State designated districts" defined
- Section 2.5-69 - "Sterile site" defined
- Section 2.5-70 - "Sterilize" defined
- Section 2.5-71 - "Suspect case" defined
- Section 2.5-72 - "Terminal cleaning" defined
- Section 2.5-73 - "Tuberculosis disease" defined
- Section 2.5-74 - "Universal precautions" defined
- Section 2.5-75 - Reporting requirements for physicians and hospital administrators
- Section 2.5-76 - Laboratories; reporting requirements
- Section 2.5-77 - Disease intervention measures; responsibility to investigate and implement
- Section 2.5-78 - Confidentiality of medical and epidemiological information
- Section 2.5-79 - General control measures
- Section 2.5-80 - Animal bites; specific control measures
- Section 2.5-81 - Anthrax; specific control measures
- Section 2.5-82 - Arboviral disease (non-neuroinvasive and neuroinvasive); specific control measures
- Section 2.5-83 - Babesiosis; specific control measures
- Section 2.5-84 - Botulism; specific control measures
- Section 2.5-85 - Brucellosis; specific control measures
- Section 2.5-86 - Campylobacteriosis; specific control measures
- Section 2.5-87 - Carbapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-CRE); specific control measures
- Section 2.5-88 - Chancroid; specific control measures
- Section 2.5-89 - Chlamydial infections, genital; specific control measures
- Section 2.5-90 - Cholera; specific control measures
- Section 2.5-91 - Coccidioidomycosis; specific control measures
- Section 2.5-92 - Cryptosporidiosis; specific control measures
- Section 2.5-93 - Cyclosporiasis; specific control measures
- Section 2.5-94 - Cysticercosis; specific control measures
- Section 2.5-95 - Diphtheria; specific control measures
- Section 2.5-96 - Ehrlichiosis; specific control measures
- Section 2.5-97 - Escherichia coli infection (Shiga toxin-producing): E. coli 0157, E. coli 0157:H7, non-0157 E. coli, and Shiga toxin detected and hemolytic uremic syndrome (HUS), postdiarrheal; specific control measures
- Section 2.5-98 - Giardiasis; specific control measures
- Section 2.5-99 - Gonorrhea; specific control measures
- Section 2.5-100 - Granuloma inguinale; specific control measures
- Section 2.5-101 - Haemophilus influenzae invasive disease; specific control measures
- Section 2.5-102 - Hansen's disease; specific control measures
- Section 2.5-103 - Hantavirus; specific control measures
- Section 2.5-104 - Hepatitis, viral, type A; specific control measures
- Section 2.5-105 - Hepatitis, viral, type B and type D; specific control measures
- Section 2.5-106 - Hepatitis C infection; specific control measures
- Section 2.5-107 - Hepatitis E infection; specific control measures
- Section 2.5-108 - Histoplasma capsulatum; specific control measures
- Section 2.5-109 - Human immunodeficiency virus infection/disease; specific control measures
- Section 2.5-110 - Influenza-associated death; specific control measures
- Section 2.5-111 - Latent tuberculosis infection; specific control measures
- Section 2.5-112 - Legionellosis; specific control measures
- Section 2.5-113 - Leptospirosis; specific control measures
- Section 2.5-114 - Listeriosis; specific control measures
- Section 2.5-115 - Lyme disease; specific control measures
- Section 2.5-116 - Lymphogranuloma venereum; specific control measures
- Section 2.5-117 - Malaria; specific control measures
- Section 2.5-118 - Measles (rubeola); specific control measures
- Section 2.5-119 - Meningococcal invasive disease; specific control measures
- Section 2.5-120 - Mumps; specific control measures
- Section 2.5-121 - Novel influenza A; specific control measures
- Section 2.5-122 - Pertussis; specific control measures
- Section 2.5-123 - Plague; specific control measures
- Section 2.5-124 - Poliomyelitis; specific control measures
- Section 2.5-125 - Psittacosis; specific control measures
- Section 2.5-126 - Q fever; specific control measures
- Section 2.5-127 - Rabies, human and animal; specific control measures
- Section 2.5-128 - Rocky Mountain spotted fever; specific control measures
- Section 2.5-129 - Rubella (German measles); specific control measures
- Section 2.5-130 - Salmonellosis, nontyphoidal; specific control measures
- Section 2.5-131 - Shigellosis; specific control measures
- Section 2.5-132 - Smallpox; specific control measures
- Section 2.5-133 - Staphylococcus aureus, vancomycin resistant level >= 8 g/mL, or severe Staphylococcus aureus in a previously healthy person; specific control measures
- Section 2.5-134 - Streptococcus pneumoniae, invasive disease; specific control measures
- Section 2.5-135 - Streptococcal invasive disease, group A and streptococcal toxic shock syndrome; specific control measures
- Section 2.5-136 - Syphilis; specific control measures
- Section 2.5-137 - Taeniasis; specific control measures
- Section 2.5-138 - Tetanus; specific control measures
- Section 2.5-139 - Toxic shock syndrome; specific control measures
- Section 2.5-140 - Trichinosis; specific control measures
- Section 2.5-141 - Tuberculosis; specific control measures
- Section 2.5-142 - Tularemia; specific control measures
- Section 2.5-143 - Typhoid and paratyphoid fever; specific control measures
- Section 2.5-144 - Typhus, endemic (fleaborne); specific control measures
- Section 2.5-145 - Varicella (chickenpox); specific control measures
- Section 2.5-146 - Vibriosis; specific control measures
- Section 2.5-147 - Yellow fever; specific control measures
- Section 2.5-148 - Yersiniosis; specific control measures
- Section 2.5-149 - Incorporation by reference
Current through March 20, 2024
Disclaimer: These regulations may not be the most recent version. Indiana may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.